Peregrine Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-641,719
Closed -$4.2M 324
2018
Q4
$4.2M Sell
641,719
-4,096
-0.6% -$45.9K 0.12% 248
2018
Q3
$11.1M Sell
645,815
-65,451
-9% -$973K 0.26% 149
2018
Q2
$9.91M Buy
711,266
+96,393
+16% +$1.63M 0.25% 143
2018
Q1
$9.43M Sell
614,873
-30,723
-5% -$439K 0.23% 158
2017
Q4
$7.44M Buy
645,596
+62,268
+11% +$927K 0.17% 217
2017
Q3
$11.1M Buy
583,328
+117,605
+25% +$2.42M 0.27% 153
2017
Q2
$11.2M Sell
465,723
-57,576
-11% -$1.26M 0.28% 151
2017
Q1
$10.6M Buy
523,299
+117,704
+29% +$2.63M 0.27% 145
2016
Q4
$9.77M Buy
405,595
+87,499
+28% +$2.44M 0.25% 182
2016
Q3
$8.83M Buy
+318,096
New +$8.41M 0.23% 203

Other funds holding PGEN

Peregrine Capital Management's PGEN Position: Q1 2019 in Review

Peregrine Capital Management sold out of Precigen (PGEN) in Q1 2019, closing a stake of 641,719 shares — an estimated $4.2M sold.

Peregrine Capital Management first reported a position in PGEN in Q3 2016 and held it in 10 quarters. The position peaked at $11.2M in Q2 2017. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

  • Peregrine Capital Management reported no remaining Precigen position as of Q1 2019 after selling out during the quarter.
  • Peregrine Capital Management sold 641,719 Precigen shares in Q1 2019, an estimated $4.2M.
  • Peregrine Capital Management first reported a position in Precigen in Q3 2016 and held it in 10 quarters.
  • Peregrine Capital Management's Precigen position peaked at $11.2M in Q2 2017.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on Peregrine Capital Management's 13F filing for Q1 2019, filed 12 Apr 2019.